Vuong Trieu
39Patents
11h-index
12Co-inventors
72Inventor score
Filing activity: Jul 13, 1998 → Aug 4, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7820788B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 161 | Active |
| US8138229B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 146 | Active |
| US7923536B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 131 | Active |
| US8314156B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 128 | Active |
| US8911786B2 | Nanoparticle comprising rapamycin and albumin as anticancer agent | Human Necessities | 57 | Active |
| US8846771B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 48 | Active |
| US9012518B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 36 | Active |
| US9012519B2 | Compositions and methods of delivery of pharmacological agents | Emerging Cross-Sectional Technologies | 36 | Active |
| US9295733B2 | SPARC binding ScFcs | Chemistry; Metallurgy | 34 | Active |
| US7332568B2 | Q3 SPARC deletion mutant and uses thereof | Physics | 32 | Expired |
| US8415304B2 | Sparc and methods of use thereof | Emerging Cross-Sectional Technologies | 12 | Active |
| US6034053A | EGF-isoflavone conjugates for the prevention of restenosis | Human Necessities | 11 | Expired |
| US8420603B2 | SPARC and methods of use thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US6172071A | Lipid-lowering quinazoline derivative | Human Necessities | 6 | Expired |
| US8383358B2 | Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy | Physics | 1 | Active |
| US7586008B2 | Propofol analogs, process for their preparation, and methods of use | Chemistry; Metallurgy | 1 | Active |
| US9763892B2 | Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods | Human Necessities | 1 | Active |
| US9758786B2 | Compositions and methods for treating pancreatic cancer | Chemistry; Metallurgy | 1 | Active |
| US9678078B2 | Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptide | Physics | 1 | Active |
| US8916204B2 | SPARC and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8821836B2 | SPARC binding peptides and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9193782B2 | Use of the SPARC microenvironment signature in the treatment of cancer | Physics | 0 | Active |
| US9671406B2 | SPARC and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8026275B2 | Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury | Human Necessities | 0 | Active |
| US10053504B2 | SPARC binding ScFvs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.